Briefings on Accreditation and Quality, February 1, 2019
This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on Accreditation and Quality.
The Joint Commission (TJC) announced revisions to its anticoagulant therapy National Patient Safety Goal (NPSG) December 7. NPSG 03.05.01 has eight new or revised elements of performance (EP).
All the changes are listed in R3 Report 19 and will take effect July 1, 2019. The update applies to all TJC-accredited hospitals, critical access hospitals, nursing care centers, and medical centers accredited under the ambulatory healthcare program.
The report explains that while this NPSG has made a positive impact on patient safety over the years, there’s been a rise in adverse events because of an increase in the use of direct oral anticoagulants (DOAC).
This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on Accreditation and Quality.
